BRAF and heart failure: Regarding cardiac failure and left ventricular failure, a meta-analysis found that treatment with BRAF/MEKi (including D + T, V + C, and E + B) was associated with a decrease in the left ventricular ejection fraction (LVEF) compared to BRAFi monotherapy [37].